BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20197700)

  • 1. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.
    Dickson DW; Baker M; Rademakers R
    Neurodegener Dis; 2010; 7(1-3):170-4. PubMed ID: 20197700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically.
    Pao WC; Dickson DW; Crook JE; Finch NA; Rademakers R; Graff-Radford NR
    Alzheimer Dis Assoc Disord; 2011; 25(4):364-8. PubMed ID: 21346515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.
    Aoki N; Murray ME; Ogaki K; Fujioka S; Rutherford NJ; Rademakers R; Ross OA; Dickson DW
    Acta Neuropathol; 2015 Jan; 129(1):53-64. PubMed ID: 25367383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential clinicopathologic and genetic features of late-onset amnestic dementias.
    Murray ME; Cannon A; Graff-Radford NR; Liesinger AM; Rutherford NJ; Ross OA; Duara R; Carrasquillo MM; Rademakers R; Dickson DW
    Acta Neuropathol; 2014 Sep; 128(3):411-21. PubMed ID: 24899141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
    Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW
    Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration.
    Rollinson S; Rohrer JD; van der Zee J; Sleegers K; Mead S; Engelborghs S; Collinge J; De Deyn PP; Mann DM; Van Broeckhoven C; Pickering-Brown SM
    Neurobiol Aging; 2011 Apr; 32(4):754-5. PubMed ID: 19446372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.
    Rademakers R; Eriksen JL; Baker M; Robinson T; Ahmed Z; Lincoln SJ; Finch N; Rutherford NJ; Crook RJ; Josephs KA; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Caselli RJ; Wszolek ZK; Uitti RJ; Feldman H; Hutton ML; Mackenzie IR; Graff-Radford NR; Dickson DW
    Hum Mol Genet; 2008 Dec; 17(23):3631-42. PubMed ID: 18723524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation at GRN 3'-UTR rs5848 is not associated with a risk of frontotemporal lobar degeneration in Dutch population.
    Simón-Sánchez J; Seelaar H; Bochdanovits Z; Deeg DJ; van Swieten JC; Heutink P
    PLoS One; 2009 Oct; 4(10):e7494. PubMed ID: 19847305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Martinez-Lage M; Sleiman PM; Hu W; Greene R; Wood EM; Bing S; Grossman M; Schellenberg GD; Hatanpaa KJ; Weiner MF; White CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach TG; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Pickering-Brown SM; Snowden J; van Swieten JC; Heutink P; Seelaar H; Murrell JR; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio E; Lladó A; Miller BL; Alzualde A; Moreno F; Rohrer JD; Mackenzie IR; Feldman HH; Hamilton RL; Cruts M; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bird TD; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van Deerlin VM
    Arch Neurol; 2011 Apr; 68(4):488-97. PubMed ID: 21482928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.
    Fenoglio C; Galimberti D; Cortini F; Kauwe JS; Cruchaga C; Venturelli E; Villa C; Serpente M; Scalabrini D; Mayo K; Piccio LM; Clerici F; Albani D; Mariani C; Forloni G; Bresolin N; Goate AM; Scarpini E
    J Alzheimers Dis; 2009; 18(3):603-12. PubMed ID: 19625741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin mutations in clinical and neuropathological Alzheimer's disease.
    Vardarajan BN; Reyes-Dumeyer D; Piriz AL; Lantigua RA; Medrano M; Rivera D; Jiménez-Velázquez IZ; Martin E; Pericak-Vance MA; Bush W; Farrer L; Haines JL; Wang LS; Leung YY; Schellenberg G; Kukull W; De Jager P; Bennett DA; Schneider JA; ; Mayeux R
    Alzheimers Dement; 2022 Dec; 18(12):2458-2467. PubMed ID: 35258170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Carter D; Cairns NJ
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease.
    Jasinska-Myga B; Wider C; Opala G; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Baker M; Rademakers R; Uitti RJ; Farrer MJ; Ross OA; Wszolek ZK
    Eur J Neurol; 2009 Aug; 16(8):909-11. PubMed ID: 19473366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
    Armstrong RA; Cairns NJ
    Histol Histopathol; 2011 Feb; 26(2):185-90. PubMed ID: 21154232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rs5848 polymorphism and serum progranulin level.
    Hsiung GY; Fok A; Feldman HH; Rademakers R; Mackenzie IR
    J Neurol Sci; 2011 Jan; 300(1-2):28-32. PubMed ID: 21047645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72.
    Murray ME; Bieniek KF; Banks Greenberg M; DeJesus-Hernandez M; Rutherford NJ; van Blitterswijk M; Niemantsverdriet E; Ash PE; Gendron TF; Kouri N; Baker M; Goodman IJ; Petrucelli L; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Oct; 126(4):545-54. PubMed ID: 23922030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.